Brief: Wilex plans rights issue using authorised capital

Heidelberg Pharma AG

04/04/2016 09:55

April 4 (Reuters) - Wilex AG  WL6G.DE : 
    * Plans rights issue using authorised capital 
    * To increase company's share capital using authorised capital from 10,679,292.00 euros by 
up to 2,248,272.00 euros to up to 12,927,564.00 euros by issuing up to 2,248,272 new no-par 
value shares 
    * Subscription price is fixed at 1.84 euro 
    * New shares will be offered to shareholders at a 19:4 ratio by means of an indirect 
subscription right by ODDO SEYDLER BANK AG 
    * Expected gross proceeds from rights issue of 4.13 million euros ($4.70 million) 
    * Subscription period will begin on April 8, 2016 and will end on April 22, 2016 
    * Plans to use proceeds to finance further development of platform technology for 
Antibody-Targeted Amanitin Conjugates (ATAC), to build own ATAC product pipeline against cancer 
diseases and to expand customer-specific research business 
 
Source text for Eikon:  ID:nEQ7hhjYsa  
Further company coverage:  WL6G.DE  
 
($1 = 0.8795 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))